Veterinary and Animal Vaccines Market Growth Drivers and Business Development Report

The global veterinary and animal vaccines market is estimated to witness a staggering CAGR by the year 2023. The burden of a wide array of infectious diseases among livestock continues to be a chief restrain to food security, economical benefits of international trade, and agricultural development. Suitable veterinary medicines are used to strategically control its outburst, enable diagnostic proficiency, and promise vaccine research using innovative technologies with public/private partnerships.

“Several veterinary and animal vaccine manufacturers have altered their prescribing methodologies by in-house pharmacy and availability of generic animal drugs so as to foster cost-effective treatments.”

The veterinary and animal vaccines market is primarily driven by the growing disposable income of millennial population and increase in pet adoption, which is anticipated to further boost during future prospects. The growing competition in the pet medicine industry is fueling the penetration of animal vaccines.

By product, the veterinary and animal vaccines market segmentation includes aquaculture vaccines, livestock vaccines, poultry vaccines, porcine vaccines, equine vaccines, companion animal vaccines, and other animal vaccines. Market split based on disease comprises Livestock Diseases, Poultry Diseases, Aquaculture Diseases, Companion Animal Disease, and miscellaneous. Based on the latest technologies used, the industry classification can be attributed to Inactivated Vaccines, Subunit Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, DNA Vaccines, Recombinant Vaccines, and Conjugate Vaccines.

Get Sample Copy of this Report @   

Geographical segmentation has presented a detailed analysis of veterinary and animal vaccines market growth prospects across the regions of North America, the Asia Pacific, Europe, the Middle East, and Africa, and Latin America. The North American market dominates the global market and its brand-name versions attributed to the incorporation of the latest technological advancements and new delivery methods.

The competitive landscape showcases the profiles and business strategies of the major players, along with their recent developments. Some of the dominant players operating in this market include Merial, Merck & Co., Inc., Ceva Sant Animale, Zoetis Inc., Sanofi S.A., Biovac, Romvac, Vaxxinova, and Anicon Labor GmbH. Some of the emerging players the market are Pfizer, Nexvet, PHL Associates, Inc., Colorado Serum Company, Hygieia Biological Laboratories, and Arko Laboratories, Ltd.

Players are entering into business partnerships with fellow contestants and are significantly investing in innovation strategies, which is estimated to drive the cellular vendors to reach new growth markets. The market participants have identified the industry cost structure, supply chain mechanism, major distribution channels, and production capabilities. They have taken into consideration several factors that have deterred the development of generic animal drugs against human medicines. The industry players are keen to incorporate restrictive distribution practices, along with selective regulatory measures so as to facilitate research and development activities that would likely benefit customers.

The veterinary and animal vaccines market competition is escalating at a steady pace with the advent of technological innovation and several Merger & Acquisition activities across the industry. Furthermore, local and regional vendors are offering specific application products for varied end-users. The new entrants and vendors in the market are finding it tough to contend with the international players based on their product quality, reliability, and innovations in technology.

Browse Related Category Market Reports @   

Matched content

Editor’s pick

Express Press Release Distribution